Saxenda® is contraindicated in people with a private or household record of MTC and in individuals with Multiple Endocrine Neoplasia syndrome kind two (Males 2). Counsel clients regarding the likely risk of MTC with use of Saxenda® and notify them of indicators of thyroid tumors (eg, a mass from the neck, dysphagia, dyspnea, persistent hoarsene